Biogen is a biotechnology company that is a pioneer in Neuroscience. The company discovers, develops, and delivers innovative therapies for people around the world living with serious neurological and neurodegenerative diseases. With the world's best neurologists and neuroscientists, Biogen is leading the industry with in-depth research and the development of medicines to transform neuroscience to benefit society.
21 Reviews
Leader in neuroscience, great colleagues, good compensation, good work-life balance
Poor culture with most decisions needing to be made by leadership, unclear strategy/vision, instability
Is this biotech an investment worth buying and holding today?
Yes, drug R&D is difficult, costly and risky. But these factors don’t really justify a high price. Value does.